Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity.
Chamberlain, S.D., Redman, A.M., Wilson, J.W., Deanda, F., Shotwell, J.B., Gerding, R., Lei, H., Yang, B., Stevens, K.L., Hassell, A.M., Shewchuk, L.M., Leesnitzer, M.A., Smith, J.L., Sabbatini, P., Atkins, C., Groy, A., Rowand, J.L., Kumar, R., Mook, R.A., Moorthy, G., Patnaik, S.(2009) Bioorg Med Chem Lett 19: 360-364
- PubMed: 19071018 
- DOI: https://doi.org/10.1016/j.bmcl.2008.11.077
- Primary Citation of Related Structures:  
3EKN, 3ELJ - PubMed Abstract: